The global payments giant reported a 15% surge in net revenue and processed a record 69.4 billion transactions in its fiscal first quarter, signaling resilient consumer confidence and a rebound from previous quarters.
Tyson Foods Inc. surpassed quarterly profit expectations, driven by resilient consumer demand for chicken. This strength helped offset significant challenges in its beef division, where historic herd shortages and soaring costs have reshaped the meat industry's landscape.
A British Columbia court has given its final approval to Coeur Mining's planned acquisition of New Gold, moving the deal that will create a North American precious metals giant one step closer to its expected H1 2026 closing.
Former President Donald Trump has announced Kevin Warsh, a former Federal Reserve governor and economic advisor, as his pick to lead the central bank. The nomination comes as incumbent Chair Jerome Powell faces a federal investigation related to his congressional testimony.
A Dominus and Cheyne Capital partnership wins City of London approval to convert the Grade II-listed Ibex House into a 382-room hotel, slated for a late 2028 opening, complete with a hospitality academy and restored pub.
Amazon's recent workforce reductions, bringing total corporate cuts to 30,000, reflect a broader shift in how layoffs are perceived. No longer framed as a sign of failure, they are increasingly presented as a strategic, forward-looking move to streamline operations and focus on priorities like AI, a narrative that resonates with investors despite the human impact.
A growing movement to eliminate state income taxes is gaining momentum, backed by the White House. However, a new analysis warns that replacing lost revenue may require significantly higher sales taxes than proponents claim, forcing a fundamental choice: accept steeper consumption taxes or shrink the size of government.
A terminal diagnosis brings immense emotional strain, but the looming question of outstanding debt adds a crushing financial burden for families. We examine the legal realities of debt inheritance, offering crucial strategies for protection and peace of mind.
Amgen has transferred full rights for the atopic dermatitis drug rocatinlimab back to Kyowa Kirin, clearing the path for the Japanese firm to pursue US approval by 2026. The move comes despite the drug meeting all trial endpoints, reflecting Amgen's portfolio reprioritization and a tempered market outlook for the OX40 inhibitor class.
A new discounted cash flow analysis suggests shares of the German industrial giant KION GROUP AG could be undervalued by nearly 30%, presenting a potential opportunity for investors amid broader market volatility.
A 15-day blackout of ESPN networks on YouTube TV last fall carved a $110 million hole in the sports giant's quarterly operating income, new financial disclosures reveal. The dispute underscores the high-stakes brinkmanship now defining relationships between content owners and distribution platforms.
A stark consensus is emerging among prediction market traders and analysts, with a 71% probability now priced in for Bitcoin to fall below $65,000 within two years. This bearish outlook follows a weekend sell-off to nine-month lows and is supported by underwater ETF positions, technical warnings, and concerns over a sustained market downturn rather than a temporary correction.
As the housing market evolves, a three-digit number remains the decisive factor for mortgage seekers. The latest FICO scoring model now considers rental history, potentially opening doors for millions of aspiring homeowners.
Cleveland-based KeyCorp (KEY) is riding a wave of positive analyst sentiment following a strong earnings beat, with its stock performance significantly outpacing broader market indices. The bank's diversified model and robust capital returns are fueling optimism for sustained growth.
A landmark tripartite agreement between financial heavyweight Schroders, battery leader CATL, and investment firm Lochpine Capital aims to deploy up to 10GWh of energy storage across Europe, marking a significant step in the continent's clean energy transition.
Pharmaceutical giant Eli Lilly enters a strategic collaboration potentially worth up to $1.93 billion with biotech firm Repertoire Immune Medicines, aiming to develop precision treatments for autoimmune diseases that move beyond broad immunosuppression.
As mortgage rates fluctuate and ambitious policy ideas emerge, economists warn that financing tweaks cannot solve the core issue: a chronic shortage of homes.
Hong Kong apparel giant Crystal International is investing in a high-tech logistics center in China, aiming to slash fabric transfer times by 75% and power operations with solar energy as part of its broader smart manufacturing push.
Chinese biotech firm Arctic Vision moves to create an integrated ophthalmology powerhouse by acquiring MDCO Technology's device business, combining drug and device expertise to address unmet needs in eye care.
Truist Securities raises its price target on Huntington Bancshares (HBAN) following a robust Q4 performance, as the regional bank forecasts record interest income growth and benefits from improving industry tailwinds.
